Cargando…

Spontaneous remission in diffuse large cell lymphoma: a case report

BACKGROUND: Spontaneous remission in solid malignancies has been documented. However, spontaneous remission in aggressive diffuse large b cell lymphoma is exceedingly rare. Previous reports of lymphoma remission suggest that not yet fully characterized tumor-intrinsic and microenvironment mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Snijder, J., Mihyawi, N., Frolov, A., Ewton, A., Rivero, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357409/
https://www.ncbi.nlm.nih.gov/pubmed/30709425
http://dx.doi.org/10.1186/s13256-018-1937-z
_version_ 1783391784873754624
author Snijder, J.
Mihyawi, N.
Frolov, A.
Ewton, A.
Rivero, G.
author_facet Snijder, J.
Mihyawi, N.
Frolov, A.
Ewton, A.
Rivero, G.
author_sort Snijder, J.
collection PubMed
description BACKGROUND: Spontaneous remission in solid malignancies has been documented. However, spontaneous remission in aggressive diffuse large b cell lymphoma is exceedingly rare. Previous reports of lymphoma remission suggest that not yet fully characterized tumor-intrinsic and microenvironment mechanisms cooperate with spontaneous regression. CASE DESCRIPTION: Here, we report the case of an 88-year-old white woman with diffuse large b cell lymphoma (follicular lymphoma transformed) who achieved morphologic spontaneous remission 3 months after her diagnostic core biopsy. We examined 16 similar cases of diffuse large b cell lymphoma suggesting that spontaneous remission is preferentially observed in elderly patients soon after their biopsy microtrauma, especially if malignancies are Epstein–Barr virus driven and activated B-cell type. CONCLUSION: Our case and reported analysis highlight that anti-tumor adaptive T cell responses are potentially augmented in a subset of patients leading to lymphoma regression. In these patients, it is possible that “primed” innate anti-tumor T cell immunity is enhanced in immunogenic lymphoma subtypes after tissue biopsy. Our case and analysis not only reinforce the role of innate T cell anticancer immunity, but also originates potential proof of concept for investigation of unexplored pathways that could favorably impact T cell therapy.
format Online
Article
Text
id pubmed-6357409
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63574092019-02-07 Spontaneous remission in diffuse large cell lymphoma: a case report Snijder, J. Mihyawi, N. Frolov, A. Ewton, A. Rivero, G. J Med Case Rep Case Report BACKGROUND: Spontaneous remission in solid malignancies has been documented. However, spontaneous remission in aggressive diffuse large b cell lymphoma is exceedingly rare. Previous reports of lymphoma remission suggest that not yet fully characterized tumor-intrinsic and microenvironment mechanisms cooperate with spontaneous regression. CASE DESCRIPTION: Here, we report the case of an 88-year-old white woman with diffuse large b cell lymphoma (follicular lymphoma transformed) who achieved morphologic spontaneous remission 3 months after her diagnostic core biopsy. We examined 16 similar cases of diffuse large b cell lymphoma suggesting that spontaneous remission is preferentially observed in elderly patients soon after their biopsy microtrauma, especially if malignancies are Epstein–Barr virus driven and activated B-cell type. CONCLUSION: Our case and reported analysis highlight that anti-tumor adaptive T cell responses are potentially augmented in a subset of patients leading to lymphoma regression. In these patients, it is possible that “primed” innate anti-tumor T cell immunity is enhanced in immunogenic lymphoma subtypes after tissue biopsy. Our case and analysis not only reinforce the role of innate T cell anticancer immunity, but also originates potential proof of concept for investigation of unexplored pathways that could favorably impact T cell therapy. BioMed Central 2019-02-01 /pmc/articles/PMC6357409/ /pubmed/30709425 http://dx.doi.org/10.1186/s13256-018-1937-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Snijder, J.
Mihyawi, N.
Frolov, A.
Ewton, A.
Rivero, G.
Spontaneous remission in diffuse large cell lymphoma: a case report
title Spontaneous remission in diffuse large cell lymphoma: a case report
title_full Spontaneous remission in diffuse large cell lymphoma: a case report
title_fullStr Spontaneous remission in diffuse large cell lymphoma: a case report
title_full_unstemmed Spontaneous remission in diffuse large cell lymphoma: a case report
title_short Spontaneous remission in diffuse large cell lymphoma: a case report
title_sort spontaneous remission in diffuse large cell lymphoma: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357409/
https://www.ncbi.nlm.nih.gov/pubmed/30709425
http://dx.doi.org/10.1186/s13256-018-1937-z
work_keys_str_mv AT snijderj spontaneousremissionindiffuselargecelllymphomaacasereport
AT mihyawin spontaneousremissionindiffuselargecelllymphomaacasereport
AT frolova spontaneousremissionindiffuselargecelllymphomaacasereport
AT ewtona spontaneousremissionindiffuselargecelllymphomaacasereport
AT riverog spontaneousremissionindiffuselargecelllymphomaacasereport